itraconazole has been researched along with Pulmonary Aspergillosis in 62 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (12.90) | 29.6817 |
| 2010's | 37 (59.68) | 24.3611 |
| 2020's | 17 (27.42) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, R; Aggarwal, AN; Chakrabarti, A; Choudhary, H; Dhooria, S; Garg, M; Muthu, V; Prasad, KT; Sehgal, IS | 1 |
| Babaei, M; Daie Ghazvini, R; Erami, M; Fattahi, M; Getso, MI; Hashemi, SJ; Khodavaisy, S; Mehri, N; Momen-Heravi, M; Parviz, S; Raiesi, O | 1 |
| Agarwal, R; Aggarwal, AN; Chakrabarti, A; Choudhary, H; Dhooria, S; Muthu, V; Prasad, KT; Rudramurthy, SM; Sehgal, IS; Vinay, K | 1 |
| Chenghao, Z; Cui, X; Ren, J; Tang, J; Wang, Y; Wu, Z | 1 |
| Matsumoto, K; Morita, K; Nakamura, Y; Sato, A | 1 |
| Apolot, D; Bongomin, F; Katende, A; Kirenga, BJ; Kwizera, R; Teu, A; Worodria, W | 1 |
| Samaddar, A; Sharma, A; Shrimali, T | 1 |
| Agarwal, R; Dhooria, S; Muthu, V; Prasad, KT; Sehgal, IS | 1 |
| Bongomin, F; Denning, DW; Garcez, T | 1 |
| Arron, ST; Brownell, I; Cahoon, EK; Cowen, EW; D'Arcy, ME; Engels, EA; Hess, GP; Israni, AK; Pfeiffer, RM; Rivera, DR; Triplette, MA; Yanik, EL | 1 |
| Bernhardt, IT; Currie, S; Jefferies, CA; Moore, P | 1 |
| Baluku, JB; Bongomin, F; Kazibwe, A; Olum, R; Russell, L | 1 |
| Dunphy, L; McKeown, E | 1 |
| Agarwal, R; Aggarwal, AN; Chakrabarti, A; Dhooria, S; Muthu, V; Prasad, KT; Sehgal, IS | 1 |
| Gabra, P; Kabra, SK; Manikanta, J; Meena, VP; Ray, A; Sethi, P; Singh, G; Singh, K; Sinha, S; Soneja, M; Vyas, S; Wig, N; Xess, I | 1 |
| Im, Y; Jeon, K; Jhun, BW; Kang, ES; Koh, WJ | 1 |
| Hashinaga, K; Hiramatsu, K; Itoh, H; Kadota, JI; Nonoshita, K; Oyama, N; Sato, Y; Suzuki, Y; Tanaka, R; Umeki, K | 1 |
| Garg, B; Goyal, RC; Mishra, A; Sood, N; Tyagi, R | 1 |
| Chi, YM; Di, QG; Du, JF; Jiang, MM; Li, M; Lv, J; Mai, ZT; Shi, J; Song, Z; Sun, BH | 1 |
| Bongomin, F; Denning, DW; Harris, C; Hayes, G; Kosmidis, C | 1 |
| Ando, T; Fujiuchi, S; Hayashi, Y; Ichihara, K; Imamura, Y; Izumikawa, K; Kakeya, H; Kishi, K; Kohno, S; Miyazaki, T; Miyazaki, Y; Mukae, H; Ogawa, K; Saijo, T; Takazono, T; Tashiro, M; Tokimatsu, I; Yamamoto, K; Yanagihara, K | 1 |
| Agarwal, R; Aggarwal, AN; Chakrabarti, A; Garg, M; Gupta, D; Vishwanath, G | 1 |
| Alberti, N; Frulio, N; Jougon, J; Jullie, ML; Palussiere, J; Trillaud, H | 1 |
| Eom, JS; Jeon, K; Jhun, BW; Koh, WJ; Kwon, OJ; Lee, JH; Suh, GY | 1 |
| Bando, T; Chen, F; Date, H; Hotta, G; Ichiyama, S; Ito, Y; Kato, K; Matsubara, K; Matsuda, Y; Matsumura, Y; Nagao, M; Nakano, S; Takakura, S; Yamamoto, M; Yunoki, T | 1 |
| Azizi, M; Denolle, T; Massart, C; Zennaro, MC | 1 |
| Brown, EV; Davoodi, P; Perry, JR; Wright, SA | 1 |
| Kikuchi, T; Kikuchi, Y; Miki, H; Nishimaki, K; Saito, W; Sasamori, K; Shishikura, Y | 1 |
| Jeon, K; Jeong, BH; Koh, WJ; Lee, SY; Moon, SM; Park, HY | 1 |
| Heinekamp, T; Jeżewska-Witkowska, G; Kasperek, K; Knaga, S; Poleszak, E; Rundfeldt, C; Winiarczyk, S; Wlaź, A; Wlaź, P; Wyska, E | 1 |
| Dabó, H; Gomes, I; Marinho, A | 1 |
| Yaguchi, T | 1 |
| Izumikawa, K; Tashiro, M | 1 |
| Bandula, S; Brown, J; Illing, R; Singh, S; Whelan, J | 1 |
| Hasegawa, A; Kamata, H; Kano, R; Kimura, S; Lim, SY; Ooya, K; Yanai, T | 1 |
| Dacruz, TA; Nalla, P; Obuobie, K | 1 |
| Jeon, K; Jhun, BW; Koh, WJ; Lee, H; Lee, SY; Moon, SM; Park, HY | 1 |
| Jakopović, M; Mazuranić, I; Miculinić, N; Plestina, S; Redzepi, G; Samarzija, M; Srdić, D | 1 |
| Fujii, H; Kaneda, T; Kaneko, M; Kubota, M; Tani, S; Tomioka, H; Tsuchimoto, K | 1 |
| Ahya, VN; Cerceo, E; Christie, JD; Gillespie, C; Hadjiliadis, D; Kotloff, RM; Pochettino, A | 1 |
| Denning, DW; Hope, WW; Howard, SJ; Lestner, JM; Moore, CB; Roberts, SA | 1 |
| Aihara, K; Fukui, M; Kagioka, H; Matsumoto, M; Nagano, M; Oguma, T; Tabata, H | 1 |
| Homasson, JP; Nguyen, TP; Tran, NT | 1 |
| Chen, W; Li, L; Li, R; Liu, W; Wan, Z; Xu, H | 1 |
| Kato, T; Ohnishi, R; Sano, K; Suzuki, T; Yasuda, S | 1 |
| Bellete, B; Flori, P; Hafid, J; Manhsung, RT; Morel, J; Raberin, H | 1 |
| Denning, DW; Lestner, JM | 1 |
| Imamura, Y; Ishimatsu, Y; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Miyazaki, T; Mukae, H; Nagayasu, T; Nakano, K; Sakamoto, N; Seki, M; Tagawa, T; Tsuchiya, T; Yamamoto, K; Yamamoto, Y; Yamasaki, N; Yanagihara, K | 1 |
| Denning, DW; Smith, NL | 1 |
| Achouh, L; Dorfmuller, P; Garcia, G; Humbert, M; Mercier, O; Montani, D; Zendah, I | 1 |
| Pena, TA; Samavati, L; Soubani, AO | 1 |
| Abe, K; Ebina, M; Gomi, K; Hisata, S; Mitsuishi, Y; Murakami, K; Muramatsu, S; Nara, M; Nukiwa, T; Tamada, T | 1 |
| Jagirdar, J; Nilsson, JR; Restrepo, CS | 1 |
| Andrade M, A; Capurro C, M; Guerra C, C; Molina E, J; Puga L, B | 1 |
| Fujii, H; Hayashi, M; Kaneda, T; Kaneko, M; Karino, T; Kida, Y; Suzuki, Y; Tada, K; Tomii, K; Tomioka, H | 1 |
| Fujita, M; Harada, E; Ikegame, S; Kajiki, A; Matsumoto, T; Nakanishi, Y; Ouchi, H; Tao, Y; Uchino, J; Watanabe, K | 1 |
| Hirano, K; Hosogaya, N; Ide, S; Imamura, Y; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Mihara, T; Miyazaki, T; Morinaga, Y; Nakamura, S; Nishino, T; Takazono, T; Tashiro, M; Tashiro, T; Tsukamoto, M; Yamamoto, Y; Yanagihara, K; Yasuoka, A | 1 |
| Chikugo, T; Enoki, E; Ito, A; Kimura, M; Maenishi, O | 1 |
| Bennett, K; Bergsson, G; Chotirmall, SH; Coughlan, CA; Dunne, K; Eshwika, A; Greene, CM; Gunaratnam, C; Hassan, T; Kavanagh, K; Logan, PM; Low, TB; McElvaney, NG; Murphy, P; Reeves, EP; Renwick, J | 1 |
| Albarrag, AM; Anderson, MJ; Bowyer, P; Denning, DW; Gregson, L; Harrison, E; Howard, SJ; Leatherbarrow, H; Pasqualotto, AC | 1 |
| Jiang, ZF; Xu, SY; Zhao, SY | 1 |
8 review(s) available for itraconazole and Pulmonary Aspergillosis
| Article | Year |
|---|---|
Pulmonary infection due to Acrophialophora fusispora in a patient with underlying mixed connective tissue disease and chronic pulmonary aspergillosis: A case report and review of literature.
Topics: Antifungal Agents; Ascomycota; Chronic Disease; Coinfection; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mixed Connective Tissue Disease; Opportunistic Infections; Pulmonary Aspergillosis | 2020 |
An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Disease Management; Echinocandins; Humans; Itraconazole; Nitriles; Practice Guidelines as Topic; Pulmonary Aspergillosis; Pyridines; Triazoles; Voriconazole | 2020 |
Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A systematic review and meta-analysis.
Topics: Administration, Oral; Antifungal Agents; Cardiotoxicity; Humans; Itraconazole; Pulmonary Aspergillosis; Treatment Outcome; Voriconazole | 2020 |
Anti-fungal agents in the treatment of chronic pulmonary aspergillosis: Systematic review and a network meta-analysis.
Topics: Antifungal Agents; Echinocandins; Humans; Itraconazole; Network Meta-Analysis; Observational Studies as Topic; Pulmonary Aspergillosis; Randomized Controlled Trials as Topic; Voriconazole | 2021 |
Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature.
Topics: Adult; Antifungal Agents; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Itraconazole; Male; Prospective Studies; Pulmonary Aspergillosis; Radiography, Thoracic; Treatment Outcome | 2013 |
The Current Status of Drug-resistant Aspergillus.
Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Japan; Mutation; Pulmonary Aspergillosis; Voriconazole | 2016 |
Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature.
Topics: Adult; Aged; Antifungal Agents; Female; Humans; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Risk Factors; Sarcoidosis, Pulmonary; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Two cases of endobronchial carcinoid masked by superimposed aspergillosis: a review of the literature of primary lung cancers associated with Aspergillus.
Topics: Aged, 80 and over; Antifungal Agents; Biopsy; Bronchial Neoplasms; Carcinoid Tumor; Comorbidity; Delayed Diagnosis; Female; Humans; Itraconazole; Lung; Middle Aged; Pneumonectomy; Pulmonary Aspergillosis; Treatment Outcome | 2013 |
6 trial(s) available for itraconazole and Pulmonary Aspergillosis
| Article | Year |
|---|---|
Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India.
Topics: Adult; Antifungal Agents; Chronic Disease; Female; Humans; India; Itraconazole; Male; Pulmonary Aspergillosis; Recurrence; Treatment Outcome | 2022 |
An open-label non-inferiority randomised control trial comparing nebulised amphotericin B with oral itraconazole in patients with pulmonary aspergilloma.
Topics: Amphotericin B; Antifungal Agents; Humans; Itraconazole; Prospective Studies; Pulmonary Aspergillosis | 2021 |
Sensitive and selective quantification of total and free itraconazole and hydroxyitraconazole in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry.
Topics: Chromatography, High Pressure Liquid; Humans; Itraconazole; Mass Spectrometry; Pulmonary Aspergillosis | 2017 |
Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature.
Topics: Adult; Antifungal Agents; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Itraconazole; Male; Prospective Studies; Pulmonary Aspergillosis; Radiography, Thoracic; Treatment Outcome | 2013 |
[An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Capsules; Chronic Disease; Female; Humans; Injections, Intravenous; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis | 2011 |
The clinical efficacy and safety of micafungin-itraconazole combination therapy in patients with pulmonary aspergilloma.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Drug Therapy, Combination; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Radiography, Thoracic; Treatment Outcome | 2012 |
49 other study(ies) available for itraconazole and Pulmonary Aspergillosis
| Article | Year |
|---|---|
COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; COVID-19; Female; Fluconazole; Humans; Iran; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; SARS-CoV-2; Voriconazole | 2023 |
Efficacy of generic forms of itraconazole capsule in treating subjects with chronic pulmonary aspergillosis.
Topics: Antifungal Agents; Humans; Itraconazole; Persistent Infection; Pulmonary Aspergillosis; Retrospective Studies; Treatment Outcome | 2023 |
Topics: Administration, Oral; Animals; Biological Availability; Drug Carriers; Itraconazole; Lipids; Nanostructures; Particle Size; Pulmonary Aspergillosis; Rabbits | 2023 |
Effective plasma concentrations of itraconazole and its active metabolite for the treatment of pulmonary aspergillosis.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Female; Humans; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Retrospective Studies; ROC Curve; Treatment Outcome | 2020 |
Algorithm-aided diagnosis of chronic pulmonary aspergillosis in low- and middle-income countries by use of a lateral flow device.
Topics: Adult; Algorithms; Anti-Retroviral Agents; Antifungal Agents; Antitubercular Agents; Aspergillus; Chronic Disease; Female; HIV Infections; Humans; Immunoglobulin G; Immunoglobulin M; Itraconazole; Poverty; Pulmonary Aspergillosis; Radiography, Thoracic; Tuberculosis, Pulmonary; Uganda | 2020 |
Impact of high baseline Aspergillus-specific IgG levels on weight and quality-of-life outcomes of patients with chronic pulmonary aspergillosis.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Fungal; Antifungal Agents; Aspergillus; Chronic Disease; Female; Humans; Immunoglobulin G; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Quality of Life; Retrospective Studies; United Kingdom; Voriconazole; Weight Loss | 2020 |
Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
Topics: Aged; Antifungal Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Incidence; Itraconazole; Lung Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Skin Neoplasms; Triazoles; United States; Voriconazole | 2020 |
Acute hyperosmolar hyperglycaemic state in cystic fibrosis-related diabetes caused by glucocorticoid and itraconazole interaction.
Topics: Adolescent; Antifungal Agents; Cystic Fibrosis; Diabetes Mellitus, Type 2; Drug Interactions; Glucocorticoids; Humans; Hyperglycemic Hyperosmolar Nonketotic Coma; Itraconazole; Male; Pulmonary Aspergillosis | 2021 |
Behind the fungus ball: pulmonary aspergillosis!
Topics: Aged, 80 and over; Antifungal Agents; Aspergillus; Early Diagnosis; Humans; Immunocompromised Host; Itraconazole; Male; Pulmonary Aspergillosis; Treatment Outcome; United Kingdom | 2020 |
Impact of treatment duration on recurrence of chronic pulmonary aspergillosis.
Topics: Antifungal Agents; Duration of Therapy; Humans; Itraconazole; Pulmonary Aspergillosis; Retrospective Studies | 2021 |
Pulmonary Hydatid Disease with Aspergillosis - An Unusual Association in an Immunocompetent Host.
Topics: Albendazole; Anticestodal Agents; Antifungal Agents; Echinococcosis, Pulmonary; Humans; Immunocompetence; Itraconazole; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Thoracic Surgery, Video-Assisted | 2019 |
Clinical efficacy of sequential therapy with voriconazole on COPD patients in acute phase with pulmonary aspergillosis and effects on cytokines and pulmonary functions.
Topics: Adult; Aged; Antifungal Agents; Cytokines; Female; Humans; Itraconazole; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Treatment Outcome; Voriconazole | 2018 |
Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Body Weight; Chronic Disease; Female; Humans; Immunoglobulin G; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Quality of Life; Retrospective Studies; Treatment Outcome; Voriconazole; Young Adult | 2018 |
Selection of Oral Antifungals for Initial Maintenance Therapy in Chronic Pulmonary Aspergillosis: A Longitudinal Analysis.
Topics: Aged; Antifungal Agents; Follow-Up Studies; Humans; Itraconazole; Maintenance; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole | 2020 |
Pulmonary aspergilloma in a cavity formed after percutaneous radiofrequency ablation.
Topics: Antifungal Agents; Biopsy, Needle; Catheter Ablation; Female; Follow-Up Studies; Humans; Immunohistochemistry; Itraconazole; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Pulmonary Aspergillosis; Rare Diseases; Sampling Studies; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis.
Topics: Administration, Oral; Aged; Antifungal Agents; Chronic Disease; Female; Humans; Itraconazole; Male; Middle Aged; Mycobacterium Infections; Pulmonary Aspergillosis; Retrospective Studies; Treatment Outcome | 2013 |
Itraconazole prophylaxis for invasive Aspergillus infection in lung transplantation.
Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Case-Control Studies; Cytomegalovirus Infections; Female; Humans; Itraconazole; Lung Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Renal Replacement Therapy; Retrospective Studies; Risk Factors; Tracheotomy | 2014 |
[Itraconazole: a new drug-related cause of hypertension].
Topics: Aged; Antifungal Agents; Humans; Hypertension; Itraconazole; Male; Pulmonary Aspergillosis; Withholding Treatment | 2014 |
Rare diagnosis in a neonate who presents with fever.
Topics: Anti-Infective Agents; Antifungal Agents; Biopsy; Diagnosis, Differential; Fever; Granulomatous Disease, Chronic; Humans; Infant, Newborn; Itraconazole; Lung; Male; Pulmonary Aspergillosis; Radiography, Interventional; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination; Voriconazole | 2015 |
[Two cases of pulmonary aspergilosis, which deteriorated with generic itraconazole].
Topics: Antifungal Agents; Drugs, Generic; Humans; Itraconazole; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Effect of rifampin and rifabutin on serum itraconazole levels in patients with chronic pulmonary aspergillosis and coexisting nontuberculous mycobacterial infection.
Topics: Aged; Antibiotics, Antitubercular; Antifungal Agents; Coinfection; Female; Humans; Itraconazole; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Pulmonary Aspergillosis; Retrospective Studies; Rifabutin; Rifampin | 2015 |
Activity and Safety of Inhaled Itraconazole Nanosuspension in a Model Pulmonary Aspergillus fumigatus Infection in Inoculated Young Quails.
Topics: Administration, Inhalation; Animals; Antifungal Agents; Aspergillus fumigatus; Coturnix; Disease Models, Animal; Drug Carriers; Female; Itraconazole; Male; Nanoparticles; Pulmonary Aspergillosis; Severity of Illness Index; Survival Analysis; Suspensions; Treatment Outcome | 2015 |
Pulmonary Aspergillus Nodule--Still Challenging?
Topics: Antifungal Agents; Aspergillus fumigatus; Biopsy; Chemical and Drug Induced Liver Injury; Chronic Disease; Diagnosis, Differential; Drug Resistance, Fungal; Drug Substitution; Female; Hemoptysis; Humans; Itraconazole; Lung Neoplasms; Middle Aged; Pulmonary Aspergillosis; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; Voriconazole | 2015 |
Deep-seated mycosis. Aspergillus lentulus.
Topics: Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Humans; Itraconazole; Microscopy, Electron, Scanning Transmission; Pulmonary Aspergillosis; Sputum; Voriconazole | 2015 |
Chronic pulmonary aspergillosis: help is on the way.
Topics: Antifungal Agents; Chronic Disease; Hemoptysis; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Practice Guidelines as Topic; Pulmonary Aspergillosis; Voriconazole | 2016 |
Aspergillosis complicating a microwave ablation cavity.
Topics: Ablation Techniques; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Itraconazole; Lung; Lung Neoplasms; Microwaves; Middle Aged; Nerve Sheath Neoplasms; Pulmonary Aspergillosis; Radiotherapy | 2016 |
The First Isolation of Aspergillus allahabadii from a Cormorant with Pulmonary Aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Bird Diseases; Birds; Child; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Pulmonary Aspergillosis; Voriconazole | 2016 |
Tiredness in a patient treated with itraconazole.
Topics: Adrenal Insufficiency; Aged; Antifungal Agents; Asthma; Bronchodilator Agents; Drug Interactions; Fatigue; Female; Fluid Therapy; Fluticasone; Glucocorticoids; Humans; Itraconazole; Pulmonary Aspergillosis; Treatment Outcome | 2017 |
Effect of a 150 mg dose of rifabutin on serum itraconazole levels in patients with coexisting chronic pulmonary aspergillosis and Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Chronic Disease; Female; Humans; Itraconazole; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pulmonary Aspergillosis; Retrospective Studies; Rifabutin | 2017 |
Recombinant factor VIIa in massive haemoptysis associated with chronic necrotising aspergillosis.
Topics: Antifungal Agents; Chronic Disease; Factor VIIa; Hemoptysis; Humans; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Recombinant Proteins; Treatment Outcome | 2008 |
[A case of pulmonary aspergilloma successfully treated with transbronchial intracavitary itraconazole].
Topics: Aged; Antifungal Agents; Female; Humans; Infusions, Intralesional; Itraconazole; Pulmonary Aspergillosis | 2008 |
Central airways obstruction due to Aspergillus fumigatus after lung transplantation.
Topics: Airway Obstruction; Antifungal Agents; Aspergillus fumigatus; Bronchoscopy; Diagnosis, Differential; Drug Therapy, Combination; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Itraconazole; Lung Transplantation; Male; Middle Aged; Opportunistic Infections; Prednisone; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Vital Capacity | 2009 |
Toxicodynamics of itraconazole: implications for therapeutic drug monitoring.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Dose-Response Relationship, Drug; Drug Monitoring; Gastrointestinal Diseases; Humans; Immunocompromised Host; Itraconazole; Logistic Models; Organ Transplantation; Pulmonary Aspergillosis; ROC Curve; Treatment Outcome; Water-Electrolyte Balance | 2009 |
[Influence of black vinegar on itraconazole absorption].
Topics: Acetic Acid; Adult; Food, Organic; Humans; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis | 2009 |
[Aspergillus niger responsible for a tracheo-oesophageal fistula in an immunocompetent patient].
Topics: Antifungal Agents; Aspergillus niger; Humans; Immunocompetence; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Tracheoesophageal Fistula; Treatment Outcome | 2009 |
Clinical itraconazole-resistant strains of Aspergillus fumigatus, isolated serially from a lung aspergilloma patient with pulmonary tuberculosis, can be detected with real-time PCR method.
Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Promoter Regions, Genetic; Pulmonary Aspergillosis; Time Factors; Tuberculosis, Pulmonary | 2010 |
[Short-term efficacy evaluation of chronic pulmonary aspergillosis treated with micafangin and maintenance therapy of itraconazole].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Chronic Disease; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Middle Aged; Pulmonary Aspergillosis | 2009 |
Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Fungal Proteins; Humans; Itraconazole; Male; Middle Aged; Mutation, Missense; Pulmonary Aspergillosis; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2010 |
Tremor: a newly described adverse event with long-term itraconazole therapy.
Topics: Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Dose-Response Relationship, Drug; Female; Humans; Itraconazole; Long-Term Care; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Pulmonary Aspergillosis; Tremor | 2010 |
Diffuse alveolar hemorrhage following itraconazole injection.
Topics: Antifungal Agents; Chronic Disease; Hemoperfusion; Hemorrhage; Humans; Injections, Intravenous; Itraconazole; Lung Diseases; Male; Middle Aged; Polymyxin B; Pulmonary Aspergillosis | 2010 |
Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma.
Topics: Adult; Aged; Aged, 80 and over; Aspergillosis; Aspergillus fumigatus; Emphysema; Female; Humans; Itraconazole; Lung Neoplasms; Male; Middle Aged; Pneumothorax; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; United Kingdom | 2011 |
Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis.
Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Combined Modality Therapy; Comorbidity; Female; Humans; Itraconazole; Lung; Middle Aged; Mycetoma; Pulmonary Aspergillosis | 2010 |
Rapid improvement of osseous sarcoidosis after the treatment of pulmonary aspergillosis by itraconazole.
Topics: Antifungal Agents; Bone Diseases; Diagnosis, Differential; Female; Fingers; Follow-Up Studies; Humans; Itraconazole; Middle Aged; Pulmonary Aspergillosis; Remission Induction; Sarcoidosis; Tomography, X-Ray Computed | 2011 |
[Itraconazole 800 mg for the prophylaxis of fungal infections in patients with acute leukemia and severe neutropenia].
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Female; Fever; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Pulmonary Aspergillosis; Young Adult | 2011 |
Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Pulmonary Aspergillosis; Time Factors; Triazoles | 2012 |
Coinfection of Aspergillus and Cryptococcus in post-tuberculosis pulmonary cavity.
Topics: Aged; Antifungal Agents; Aspergillus; Coinfection; Cryptococcosis; Cryptococcus; Humans; Itraconazole; Lung; Male; Pulmonary Aspergillosis; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillus fumigatus; Blotting, Western; Bronchi; Cells, Cultured; Cystic Fibrosis; Down-Regulation; Epithelium; Female; Gliotoxin; Humans; Immunosuppressive Agents; Interleukin-13; Interleukin-5; Itraconazole; Male; Pulmonary Aspergillosis; Receptors, Calcitriol; Reverse Transcriptase Polymerase Chain Reaction; Th2 Cells; Trachea; Young Adult | 2012 |
Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis.
Topics: Adult; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Female; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Middle Aged; Molecular Typing; Mycological Typing Techniques; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2013 |
[Diagnosis and treatment of chronic pulmonary aspergillosis in 4 children].
Topics: Amphotericin B; Child; Child, Preschool; Chronic Disease; Drug Therapy, Combination; Female; Humans; Infant; Itraconazole; Male; Pulmonary Aspergillosis | 2005 |